24th

October

2025

US Connect 2026 – Early Bird Registration is Open!
1 day to go!
Get Involved

28th

October

2025

Safety Analytics Webinar – Registration is Open!
5 days to go!
Get Involved

29th

October

2025

October Webinar Wednesday - Registration is Open!
6 days to go!
Get Involved

16th

November

2025

EU Connect 2025 – Registration is Open!
24 days to go!
Get Involved

21st

February

2026

APAC Connect 2026 – Registration is Open!
121 days to go!
Get Involved
  1. Home
  2. /
  3. Communications
  4. /
  5. PHUSE Blog

Participant Data Return Survey Results

Participant data return is the act of granting clinical trial participants access to the data that was collected about them during a clinical trial. In current clinical trial practice, we take measurements, conduct tests, and perform procedures. The results are reviewed by the investigator and stored by the sponsor, but participants rarely see their own results.

Category: Working Groups News

Summary of the Panel Discussion on the EMA CHMP Clinical Study Data Submission Pilot at the PHUSE US Connect 2025

At the PHUSE US Connect 2025, I had the opportunity to moderate a panel featuring representatives from the European Medicines Agency (EMA), Genentech, PHUSE and others, focused on the evolving future of data submissions in the EU.

Category: Events Across the Globe

PHUSE Data Transparency Autumn Event 2025 Summary

The Data Transparency Autumn Event 2025 brought together 519 attendees spanning 140 companies and 25 countries. With discussions on evolving policies, the ethical responsibilities of data sharing, the challenges of privacy and risk management, and AI and innovation, the event offered a rich mix of perspectives and expertise, with Q&A sessions fueling thought-provoking discussions.

Category: Events Across the Globe

Statistical Strategies for Quality by Design under ICH E6(R3)

Quality by Design (QbD) is a systematic approach to product development, particularly in pharmaceuticals and clinical trials, aimed at ensuring that quality is built into the design, conduct and monitoring of a study from the outset. The ICH E6(R3) Good Clinical Practice (GCP) guideline introduces a framework that promotes flexibility in study conduct, modernisation of trial approaches, and greater efficiency in clinical trial execution. Statistical elements are central to achieving these objectives.

Category: Industry Topics

1of65